A PRECIPITATION PROCESS FOR AMORPHOUS LETERMOVIR
A precipitation process for amorphous Letermovir, contains residual solvents in accordance with ICH guidelines and is suitable for the preparation of orally administered pharmaceutical formulations. The formulations of the amorphous Letermovir are intended for use in methods of prophylaxis or method...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A precipitation process for amorphous Letermovir, contains residual solvents in accordance with ICH guidelines and is suitable for the preparation of orally administered pharmaceutical formulations. The formulations of the amorphous Letermovir are intended for use in methods of prophylaxis or methods of treatment of viral diseases, in particular human cytomegalovirus (HCMV) infections. |
---|